135 related articles for article (PubMed ID: 11862195)
1. Toxic epidermal necrolysis treated with N-acetylcysteine.
Vélez A; Moreno JC
J Am Acad Dermatol; 2002 Mar; 46(3):469-70. PubMed ID: 11862195
[No Abstract] [Full Text] [Related]
2. Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine.
Redondo P; de Felipe I; de la Peña A; Aramendia JM; Vanaclocha V
Br J Dermatol; 1997 Apr; 136(4):645-6. PubMed ID: 9155988
[No Abstract] [Full Text] [Related]
3. Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study.
Paquet P; Jennes S; Rousseau AF; Libon F; Delvenne P; Piérard GE
Burns; 2014 Dec; 40(8):1707-12. PubMed ID: 24726294
[TBL] [Abstract][Full Text] [Related]
4. Toxic epidermal necrolysis treated with N-acetylcysteine.
Yavuz H; Emiroglu M
Pediatr Int; 2014 Oct; 56(5):e52-4. PubMed ID: 25336009
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
[TBL] [Abstract][Full Text] [Related]
6. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
8. The management of toxic epidermal necrolysis.
Fernando SL
Australas J Dermatol; 2012 Aug; 53(3):165-71. PubMed ID: 22881464
[TBL] [Abstract][Full Text] [Related]
9. RF - Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Treatment Update.
de Quintana-Sancho A; Rubio-Lombraña M; Guergue Díaz-de-Cerio O; Barrutia-Borque A
Actas Dermosifiliogr; 2016 Apr; 107(3):247-8. PubMed ID: 26138285
[No Abstract] [Full Text] [Related]
10. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
[TBL] [Abstract][Full Text] [Related]
11. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
12. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].
Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S
Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180
[TBL] [Abstract][Full Text] [Related]
13. Outcome of Stevens Johnson syndrome and toxic epidermal necrolysis treated with corticosteroids.
Rijal A; Agrawal S
Indian J Dermatol Venereol Leprol; 2009; 75(6):613-4. PubMed ID: 19915248
[No Abstract] [Full Text] [Related]
14. Are steroids effective in toxic epidermal necrolysis and Stevens-Johnson syndrome?
Meza R; Rada G; Varas P
Medwave; 2017 Apr; 17(Suppl2):e6894. PubMed ID: 28430767
[TBL] [Abstract][Full Text] [Related]
15. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
[TBL] [Abstract][Full Text] [Related]
16. Pentoxyfylline in toxic epidermal necrolysis and Stevens-Johnson syndrome.
Sanclemente G; De la Roche CA; Escobar CE; Falabella R
Int J Dermatol; 1999 Nov; 38(11):878-9. PubMed ID: 10583942
[No Abstract] [Full Text] [Related]
17. Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.
Gavigan GM; Kanigsberg ND; Ramien ML
J Cutan Med Surg; 2018; 22(5):514-515. PubMed ID: 29421925
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Gilbert M; Scherrer LA
Dermatol Ther; 2019 Jan; 32(1):e12758. PubMed ID: 30285308
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of toxic epidermal necrolysis/Stevens-Johnson syndrome overlap with human granulocyte colony stimulating factor: a case report.
Pallesen KA; Robinson S; Toft P; Andersen KE
Acta Derm Venereol; 2012 Mar; 92(2):212-3. PubMed ID: 22068367
[No Abstract] [Full Text] [Related]
20. Systemic and local management at the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
Sotozono C; Ueta M; Kinoshita S
Am J Ophthalmol; 2010 Feb; 149(2):354; author reply 355. PubMed ID: 20103059
[No Abstract] [Full Text] [Related]
[Next] [New Search]
